Woodmont Investment Counsel LLC Organon & Co. Transaction History

Woodmont Investment Counsel LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$23.31 - $28.61 $168,904 - $207,308	-7,246 Reduced 10.34%	62,818 $1.76 Million
Q3 2022 Nov 08, 2022	SELL	$23.4 - $34.25 $190,125 - $278,281	-8,125 Reduced 10.39%	70,064 $1.64 Million
Q2 2022 Aug 09, 2022	SELL	$31.66 - $38.9 $94,473 - $116,077	-2,984 Reduced 3.68%	78,189 $2.64 Million
Q1 2022 May 12, 2022	BUY	$30.45 - $39.36 $178,771 - $231,082	5,871 Added 7.8%	81,173 $2.84 Million
Q4 2021 Feb 02, 2022	BUY	$28.67 - $37.13 $87,529 - $113,357	3,053 Added 4.23%	75,302 $2.29 Million
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $1.09 Million - $1.35 Million	37,999 Added 110.95%	72,249 $2.37 Million
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $974,412 - $1.3 Million	34,250 New	34,250 $1.04 Million

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Woodmont Investment Counsel LLC, based on Form 13F filings with the SEC.

Stay updated on Woodmont Investment Counsel LLC with notifications on news.